Radnor Capital Management, LLC Amgen Inc Transaction History

Radnor Capital Management, LLC

$328 Million
Q2 2024

A detailed history of Radnor Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Radnor Capital Management, LLC holds 7,035 shares of AMGN stock, worth $2.26 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

7,035

Previous 6,960 1.08%

Holding current value

$2.26 Million

Previous $1.98 Million 11.07%

% of portfolio

0.67%

Previous 0.34%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $19,706 - $23,948	75 Added 1.08%	7,035 $2.2 Million
Q4 2023 Jan 11, 2024	BUY	$255.7 - $288.46 $15,342 - $17,307	60 Added 0.87%	6,960 $2.01 Million
Q3 2023 Oct 12, 2023	BUY	$218.65 - $271.46 $1.51 Million - $1.87 Million	6,900 New	6,900 $1.85 Million
Q1 2023 Apr 06, 2023	BUY	$225.79 - $275.2 $42,900 - $52,288	190 Added 2.43%	8,000 $1.93 Million
Q4 2022 Jan 09, 2023	BUY	$229.03 - $291.01 $178,643 - $226,987	780 Added 11.1%	7,810 $2.13 Million
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $164,529 - $185,558	733 Added 11.64%	7,030 $1.59 Million
Q2 2022 Jul 11, 2022	BUY	$230.71 - $256.74 $13,842 - $15,404	60 Added 0.96%	6,297 $1.53 Million
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $16,445 - $18,192	-75 Reduced 1.19%	6,237 $1.51 Million
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $1.26 Million - $1.44 Million	6,312 New	6,312 $1.42 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $468,479 - $548,880	-2,207 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $5,409 - $6,441	25 Added 1.15%	2,207 $507,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $44,583 - $49,580	190 Added 9.54%	2,182 $555,000
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $4,167 - $4,885	25 Added 1.27%	1,992 $367,000
Q2 2017 Aug 09, 2017	BUY	N/A	1,967	1,967 $339,000

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Account

Radnor Capital Management, LLC Amgen Inc Transaction History